Compare, Analyse IPCA Labs with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs MYLAN (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   MYLAN
EQUITY SHARE DATA
    IPCA LABS
Mar-19
MYLAN
Dec-18
IPCA LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0423,552-   
Low Rs5901,955-   
Sales per share (Unadj.) Rs298.61,634.4-  
Earnings per share (Unadj.) Rs35.044.4-  
Cash flow per share (Unadj.) Rs49.4350.4-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.11,768.1-  
Shares outstanding (eoy) m126.35514.50-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.7 162.2%   
Avg P/E ratio x23.362.0 37.6%  
P/CF ratio (eoy) x16.57.9 210.1%  
Price / Book Value ratio x3.31.6 212.0%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1081,416,664 7.3%   
No. of employees `00013.435.0 38.4%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.024,025.5 11.7%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0652.4 50.4%   
INCOME DATA
Net Sales Rs m37,732840,893 4.5%  
Other income Rs m5770-   
Total revenues Rs m38,309840,893 4.6%   
Gross profit Rs m6,901217,592 3.2%  
Depreciation Rs m1,824157,448 1.2%   
Interest Rs m18940,444 0.5%   
Profit before tax Rs m5,46519,700 27.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042-3,134 -33.3%   
Profit after tax Rs m4,42222,834 19.4%  
Gross profit margin %18.325.9 70.7%  
Effective tax rate %19.1-15.9 -119.9%   
Net profit margin %11.72.7 431.6%  
BALANCE SHEET DATA
Current assets Rs m23,778469,554 5.1%   
Current liabilities Rs m10,975342,357 3.2%   
Net working cap to sales %33.915.1 224.3%  
Current ratio x2.21.4 158.0%  
Inventory Days Days10484 124.2%  
Debtors Days Days6693 70.6%  
Net fixed assets Rs m20,368163,119 12.5%   
Share capital Rs m253448 56.4%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,224909,692 3.4%   
Long term debt Rs m1,409981,850 0.1%   
Total assets Rs m45,5072,440,149 1.9%  
Interest coverage x30.01.5 2,014.6%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.80.3 240.6%   
Return on assets %10.12.6 390.7%  
Return on equity %14.22.5 564.2%  
Return on capital %17.33.2 544.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923174,738 2.8%  
From Investments Rs m-1,563-90,320 1.7%  
From Financial Activity Rs m-1,832-81,403 2.3%  
Net Cashflow Rs m1,5281,448 105.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.62 Rs / USD

Compare IPCA LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: PANACEA BIOTECH  J.B.CHEMICALS  ELDER PHARMA  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Jul 7, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 5-YR ANALYSIS

COMPARE IPCA LABS WITH

FEATURED VIDEOS

MARKET STATS